Send us Fan Mail
Ozempic and similar drugs are dominating the conversation about culture, health, and financial markets right now. But what does it mean for Wall Street --- not just for investors, but also in terms of its impact on the social norms of the industry? **TRIGGER WARNING: This episode contains a discussion of eating disorders and disordered ea ... Show More
Sep 2025
E37 - Ozempic & Your Mental Health
Let's dive into the rise of GLP-1 medications and what they mean for both the body and the mind. From Serena Williams stepping in as the face of Ro’s GLP-1 campaign, to Kyla’s personal weight loss journey, we explore the intersections of medicine, celebrity culture, and lived exp ... Show More
28m 20s
Apr 2023
Encore: Diet Wars | Dieting 3.0 | 5
First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ... Show More
39m 12s
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Mar 2025
Remi’s Honest 2-Year Ozempic Update
Trigger Warning: In this episode, we discuss binge eating, eating disorders, body image, and negative thoughts. If these topics are sensitive for you, feel free to skip this episode or listen with care. 💜Ready for a wellness check in?! On this week’s episode, we’re diving into a ... Show More
59m 9s
Oct 2023
Weightloss Drug OZEMPIC: What They're NOT Telling You! With Lee Fang
<p>Russell chats to Lee Fang, an independent journalist on Substack, who worked for Elon on the Twitter Files revelations, about a drugmaker appearing to push for profit over health with a new weightloss drug, Ozempic. with the obesity treatment market projected to reach $71 bil ... Show More
44m 39s
Dec 2024
Deep Dive: The Gold Rush to Cure the Obesity Epidemic
<p>GLP-1 weight-loss drugs, such as Novo Nordisk's Ozempic and Eli Lilly's Zepbound, are credited with reversing obesity trends in the U.S. for the first time in decades, according to a new study in the Journal of the American Medical Association. The episode highlights the rapid ... Show More
8m 47s